Day: November 18, 2019

InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and Medical Officer

REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVenn Biosciences, a company in the life sciences and technology sector, is pleased to announce that the...

Fresenius Kabi starts United for Clinical Nutrition initiative in Europe with first-of-its-kind clinical study assessing critically ill patients in 11 European countries

Genentech to Present New and Updated Data for Seven Approved and Investigational Medicines Across Multiple Types of Breast Cancer at the 2019 San Antonio Breast Cancer Symposium

— Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer — — Follow-up data from pivotal Phase...

error: Content is protected !!